摘要
目的:分析临床优质护理干预在紫杉醇同步放化疗治疗局部晚期非小细胞肺癌中的应用效果。方法:将68例进行紫杉醇同步放化疗治疗的局部晚期非小细胞肺癌患者随机分为研究组和对照组,每组34例。对照组予以常规护理干预,研究组予以优质护理干预。比较两组患者的不良情绪评分情况、近期疗效和护理满意度情况。结果:护理后,研究组焦虑自评量表(SAS)、抑郁自评量表(SDS)评分均低于对照组,且组间差异均具有统计学意义(P<0.05);研究组的治疗总有效率、总满意率(91.18%、97.06%)均高于对照组(70.59%、79.41%),且组间差异均具有统计学意义(P<0.05)。结论:针对进行紫杉醇同步放化疗的局部晚期非小细胞肺癌患者,采用优质护理干预可对有效缓解患者的不良情绪,改善近期疗效,进而提高患者的护理满意率,值得推广。
Objective: To analyze the effect of high-quality nursing intervention in the treatment of local advanced non-small cell lung cancer with paclitaxel. Methods: Sixty-eight patients with locally advanced non-small cell lung cancer treated with paclitaxel combined radiotherapy and chemotherapy were randomly divided into study group and control group with 34 cases in each group. The control group was given routine nursing intervention, while the study group was given quality nursing intervention. The scores of bad emotion, short-term efficacy and nursing satisfaction were compared between the two groups. Results: After nursing care, the scores of SAS(Self-Rating anxiety scale), SDS(Self-Rating depression scale) in the study group were significantly lower than those in the control group(P<0.05). The total effective rate and satisfaction rate(91.18% and97.06%) of the study group were significantly higher than that of the control group(70.599.41%)(P<0.05). Conclusion: For the patients with locally advanced non-small cell lung cancer treated with paclitaxel concurrent radiotherapy and chemotherapy, the high quality nursing intervention can effectively relieve the bad emotion of the patients, improve the short-term curative effect, and improve the nursing satisfaction rate of the patients,which is worth popularizing.
引文
[1]石安辉,朱广迎.局部晚期非小细胞肺癌放化疗的现状与进展[J].临床外科杂志, 2016, 24(7):505-508.
[2]宋晓,张志林,席强,等.多西紫杉醇联合同步放疗治疗局部晚期非小细胞肺癌的临床观察[J].国际呼吸杂志, 2016, 36(22):1703-1706.
[3]冯谢敏,赵红,崔洁,等.同步放化疗治疗局部晚期非小细胞肺癌疗效观察[J].陕西医学杂志, 2016, 45(9):1126-1128.
[4]赵静,张晓彤,胡克,等.紫杉醇联合卡铂三周方案同步胸部放疗治疗不宜手术的局部晚期非小细胞肺癌疗效和安全性研究:一项来自单中心的回顾性研究[J].中国肺癌杂志, 2016, 19(11):731-737.
[5]尚华,王艳美,张晕生.紫杉醇联合奈达铂同步放疗治疗局部晚期非小细胞肺癌的临床疗效及安全性观察[J].临床肺科杂志, 2017, 22(10):1870-1873.
[6]张瑞光,伍钢.局部晚期非小细胞肺癌的治疗[J].临床外科杂志,2018,26(3):174-176.
[7]不可手术局部晚期非小细胞肺癌患者预后的影响因素研究[J].实用心脑肺血管病杂志, 2016, 24(9):51-54.
[8]应申鹏,刘艳梅,娄鹏荣,等.局部晚期非小细胞肺癌根治性放疗患者感染病原菌分布与危险因素分析[J].中华医院感染学杂志, 2016, 26(1):95-97.
[9]119例局部晚期非小细胞肺癌放化疗后预后分析[J].临床肺科杂志,2017, 22(8):1481-1485.
[10]崔媛媛,李杭,张瑜.局部晚期非小细胞肺癌预防性脑照射的研究进展[J].中华肿瘤杂志, 2016, 38(1):1-3.
[11]放化疗对局部晚期非小细胞肺癌患者外周血V EGF的影响[J].实用癌症杂志, 2016, 31(12):1936-1939.
[12]周子洋,宋晓,吴爱鲁,等.局部晚期非小细胞肺癌放疗后重症放射性肺炎相关因素分析[J].广东医学, 2017, 38(11):1703-1706.